Published in Neurology on February 20, 2007
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. J Am Coll Cardiol (2010) 2.17
Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS). Arch Neurol (2009) 1.74
Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol (2013) 1.12
Lipids and carotid plaque in the Northern Manhattan Study (NOMAS). BMC Cardiovasc Disord (2009) 1.04
Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study. JACC Cardiovasc Imaging (2014) 0.93
Lipid and lipoprotein biomarkers and the risk of ischemic stroke in postmenopausal women. Stroke (2012) 0.92
Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study. Cardiovasc Diabetol (2011) 0.91
Racial and geographic differences in prevalence, awareness, treatment and control of dyslipidemia: the reasons for geographic and racial differences in stroke (REGARDS) study. Neuroepidemiology (2011) 0.86
Lipid and lipoprotein measurements and the risk of ischemic vascular events: Framingham Study. Neurology (2015) 0.86
A study of serum apolipoprotein A1, apolipoprotein B and lipid profile in stroke. J Clin Diagn Res (2013) 0.80
Ischemic stroke among the patients with end-stage renal disease who were undergoing maintenance dialysis. Yonsei Med J (2012) 0.80
Stroke Risk Factors, Genetics, and Prevention. Circ Res (2017) 0.78
Racial differences in the association of insulin resistance with stroke risk: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke (2014) 0.78
Low total cholesterol level is the independent predictor of poor outcomes in patients with acute ischemic stroke: a hospital-based prospective study. BMC Neurol (2016) 0.78
Lipids and Cerebrovascular Disease: Research and Practice. Stroke (2015) 0.78
What is the association of lipid levels and incident stroke? Int J Cardiol (2016) 0.77
Low HDL cholesterol is correlated to the acute ischemic stroke with diabetes mellitus. Lipids Health Dis (2014) 0.77
Lipid profiles and ischemic stroke risk: variations by sex within racial/ethnic groups. Int J Womens Health (2014) 0.76
Cardiological evaluation after cerebral ischaemia : Consensus statement of the Working Group Heart and Brain of the German Cardiac Society-Cardiovascular Research (DGK) and the German Stroke Society (DSG). Clin Res Cardiol (2010) 0.76
Study of genetic, metabolic and inflammatory risk factors in patients of acute ischemic stroke. Indian J Clin Biochem (2008) 0.75
Estimates of commercial population at high risk for cardiovascular events: impact of aggressive cholesterol reduction. Am Health Drug Benefits (2009) 0.75
Synergistic effects of elevated homocysteine level and abnormal blood lipids on the onset of stroke. Neural Regen Res (2013) 0.75
Sex differences in outcomes after stroke among patients with low total cholesterol levels: a large hospital-based prospective study. Biol Sex Differ (2016) 0.75
Exposure to traffic-generated air pollutants mediates alterations in brain microvascular integrity in wildtype mice on a high-fat diet. Environ Res (2017) 0.75
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74
Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med (1993) 5.19
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet (2004) 5.19
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med (1989) 4.31
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation (2001) 4.21
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet (1996) 3.95
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation (2005) 3.85
Cardiovascular risk factors and migraine: the GEM population-based study. Neurology (2005) 2.86
High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA (2001) 2.85
Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet (1998) 2.71
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57
Pravastatin therapy and the risk of stroke. N Engl J Med (2000) 2.46
Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke (2004) 2.41
Healthy lifestyle and the risk of stroke in women. Arch Intern Med (2006) 2.02
Migraine, headache, and the risk of stroke in women: a prospective study. Neurology (2005) 2.01
Interobserver agreement in the classification of stroke in the Women's Health Study. Stroke (2003) 1.81
Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation (2004) 1.78
Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology (2004) 1.72
Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke (2003) 1.58
Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study. BMJ (2006) 1.51
Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. Stroke (1999) 1.42
Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke (1999) 1.15
Factors related to stroke incidence in Hawaii Japanese men. The Honolulu Heart Study. Stroke (1980) 1.14
HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke (2000) 1.13
High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke (1997) 1.12
Cholesterol and the risk of ischemic stroke. Stroke (2003) 1.11
Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study. Arch Intern Med (2005) 1.08
A prospective study of plasma lipid levels and hypertension in women. Arch Intern Med (2005) 1.08
Cholesterol predicts stroke mortality in the Women's Pooling Project. Stroke (2002) 1.04
Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk. Stroke (1994) 1.04
Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch Intern Med (2002) 0.88
Influence of physical work on high density lipoprotein cholesterol: implications for the risk of coronary heart disease. Int J Sports Med (1994) 0.85
Serum cholesterol and risk of ischemic stroke: results of a case-control study. On behalf of PROGETTO 3A Investigators. Prev Med (1995) 0.79
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation (1989) 6.87
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA (2001) 5.54
Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med (1993) 5.19
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med (2000) 4.84
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54
Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA (1997) 4.37
Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst (1999) 4.27
Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol (2000) 4.21
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr (2000) 3.99
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
A prospective study of cigarette smoking and risk of cataract in men. JAMA (1992) 3.72
Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA (1996) 3.69
Physical activity and coronary heart disease in women: is "no pain, no gain" passé? JAMA (2001) 3.65
The primary prevention of coronary heart disease in women. N Engl J Med (1995) 3.40
Light-to-moderate alcohol consumption and risk of stroke among U.S. male physicians. N Engl J Med (1999) 3.21
Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem (2001) 3.12
Mortality and light to moderate alcohol consumption after myocardial infarction. Lancet (1998) 3.06
Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA (1988) 3.04
Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology (2004) 2.97
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Novel clinical markers of vascular wall inflammation. Circ Res (2001) 2.80
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med (2002) 2.70
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem (2001) 2.67
Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr (2001) 2.64
The primary prevention of myocardial infarction. N Engl J Med (1992) 2.63
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Blood pressure and inflammation in apparently healthy men. Hypertension (2001) 2.55
Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst (1993) 2.52
Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol (2001) 2.50
Adjunctive drug therapy of acute myocardial infarction--evidence from clinical trials. N Engl J Med (1996) 2.48
Hormone replacement therapy and dry eye syndrome. JAMA (2001) 2.46
Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem (1999) 2.35
Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann Intern Med (1995) 2.31
A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA (1996) 2.27
Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension (2000) 2.23
Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes Relat Metab Disord (2001) 2.20
Intracerebral hemorrhage: external validation and extension of a model for prediction of 30-day survival. Ann Neurol (1991) 2.20
Ways of measuring rates of recurrent events. BMJ (1996) 2.18
Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested. JAMA (1995) 2.15
The pravastatin inflammation CRP evaluation (PRINCE): rationale and design. Am Heart J (2001) 2.12
The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc (1999) 2.12
Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. J Am Coll Cardiol (2001) 2.11
Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation (1997) 2.10
A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum (1999) 2.09
Low-dose aspirin for migraine prophylaxis in women. Cephalalgia (2001) 2.07
Secular trends in stroke incidence and mortality. The Framingham Study. Stroke (1992) 2.07
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem (2001) 2.06
Estimating the effect of the run-in on the power of the Physicians' Health Study. Stat Med (1991) 2.05
Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest (1999) 2.03
HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. Diabetologia (2007) 2.03
Migraine, headache, and the risk of stroke in women: a prospective study. Neurology (2005) 2.01
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem (2001) 2.01
Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet (2005) 2.00
Large-scale trials of thrombolytic therapy for acute myocardial infarction: GISSI-2, ISIS-3, and GUSTO-1. Ann Intern Med (1993) 1.97
Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation (1999) 1.96
Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA (1997) 1.94
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med (1992) 1.92
Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92
Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med (1999) 1.91
Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation (2001) 1.86
Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia (2007) 1.80
Trans-fatty acids intake and risk of myocardial infarction. Circulation (1994) 1.78
Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia (2009) 1.77
Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med (1998) 1.71
US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol (2000) 1.71
Soluble P-selectin and the risk of future cardiovascular events. Circulation (2001) 1.69
Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia (2009) 1.69
Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol (1993) 1.68
The pilot Stroke Data Bank: definition, design, and data. Stroke (1984) 1.67
A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol (1995) 1.66
Stroke in south Alabama: incidence and diagnostic features--a population based study. Stroke (1984) 1.66
Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases. Arch Neurol (1974) 1.65
Novel inflammatory markers of coronary risk: theory versus practice. Circulation (1999) 1.65
Exercise and risk of stroke in male physicians. Stroke (1999) 1.65
Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology (2008) 1.63
Height and incidence of cardiovascular disease in male physicians. Circulation (1993) 1.62
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol (2000) 1.62
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost (2006) 1.62